Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report) traded down 3.9% during mid-day trading on Tuesday . The company traded as low as $0.03 and last traded at $0.71. 5,696 shares were traded during mid-day trading, an increase of 171% from the average session volume of 2,099 shares. The stock had previously closed at $0.74.
Fresh Tracks Therapeutics Trading Down 3.9 %
The firm’s 50-day moving average is $0.73 and its 200 day moving average is $0.79. The firm has a market capitalization of $4.25 million, a price-to-earnings ratio of -0.50 and a beta of 0.51.
Fresh Tracks Therapeutics Company Profile
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
Featured Articles
- Five stocks we like better than Fresh Tracks Therapeutics
- Insider Trades May Not Tell You What You Think
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Consumer Staples Stocks, Explained
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- What is Put Option Volume?
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
